AIM IMMUNOTECH INC. Proceeds from Sale of Available-for-sale Securities
AIM IMMUNOTECH INC. (AIM) reported Proceeds from Sale of Available-for-sale Securities of $4.69 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2019-04-01
- AIM IMMUNOTECH INC. proceeds from sale of available-for-sale securities for fiscal 2018 was $4.69M.
| Period end | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|
| 2018-12-31 | $4.69M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |